Carol S. Surowy

Novel Transient Receptor Potential Vanilloid 1 Receptor Antagonists for the Treatment of Pain:  Structure−Activity Relationships for Ureas with Quinoline, Isoquinoline, Quinazoline, Phthalazine, Quinoxaline, and Cinnoline Moieties

Arthur Gomtsyan, Erol K. Bayburt, Robert G. Schmidt et al. · Journal of Medicinal Chemistry · 2005 · 163 citations · Full text

Pain Medicine, Immunology, Receptor Antagonists +18

Synthesis and Evaluation of Benzothiazole-Based Analogues as Novel, Potent, and Selective Fatty Acid Amide Hydrolase Inhibitors

Xueqing Wang, Katerina Sarris, Karen Kage et al. · Journal of Medicinal Chemistry · 2008 · 149 citations · Full text

Drug Target, Organic Chemistry, Chemical Biology +17

The human U1-70K snRNP protein: cDNA cloning, chromosomal localization, expression, alternative splicing and RNA-binding

Richard A. Spritz, Kathleen M. Strunk, Carol S. Surowy et al. · Nucleic Acids Research · 1987 · 146 citations · Full text

Repeated dosing of ABT-102, a potent and selective TRPV1 antagonist, enhances TRPV1-mediated analgesic activity in rodents, but attenuates antagonist-induced hyperthermia

Prisca Honoré, Prasant Chandran, Gricelda Hernandez et al. · Pain · 2009 · 145 citations

A-425619 [1-Isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a Novel and Selective Transient Receptor Potential Type V1 Receptor Antagonist, Blocks Channel Activation by Vanilloids, Heat, and Acid

Rachid El Kouhen, Carol S. Surowy, Bruce R. Bianchi et al. · Journal of Pharmacology and Experimental Therapeutics · 2005 · 110 citations